Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.459NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.459NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.117NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.117NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.117NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.381NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.381NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.237NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.237NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.382NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.382NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.395NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.395NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.395NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.153NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.153NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.153NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.391NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.391NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.391NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.448NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.448NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.448NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.1 (Alpha)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Q.1 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.1 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used